Gerofit Exercise for Sickle Cell Disease
(SICKLE-FIT Trial)
Trial Summary
The trial information does not specify whether you need to stop taking your current medications.
The Gerofit Exercise Program has shown significant health benefits for older veterans, including improved physical function, well-being, and a 25% survival benefit over 10 years. These benefits suggest that structured exercise programs like Gerofit can provide long-lasting health improvements, which may also be beneficial for individuals with chronic conditions such as Sickle Cell Disease.
12345Research shows that moderate exercise can be safe for people with sickle cell disease, as studies found no exercise-related adverse events in children and suggest that patient-adapted exercise programs can be safe. However, high-intensity exercise may pose risks, so it's important to follow tailored exercise guidelines.
678910The Gerofit Exercise Program is unique because it focuses on structured exercise as a primary therapeutic approach, promoting long-term health benefits and improved physical function, which is different from traditional medical treatments for sickle cell disease that often focus on medication and pain management.
13111213Eligibility Criteria
This trial is for adults with Sickle Cell Disease (SCD) who can speak English fluently. Participants must have a confirmed diagnosis of any genotype of SCD. It's not suitable for those with unstable heart disease, severe cognitive issues, wheelchair users, oxygen-dependent individuals, or those who've had successful stem cell transplants for SCD.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants engage in a personalized exercise program adapted from Gerofit, exercising 3 days a week for up to 12 weeks
Follow-up
Participants are monitored for safety and effectiveness after treatment, including Sickle Cell Disease Functional Assessment every 3 months
Participant Groups
Gerofit Exercise Program is already approved in United States for the following indications:
- Improving physical health and quality of life in older adults
- Preventing mobility decline in older veterans